Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/00015385.2017.1320021 | DOI Listing |
Wiad Lek
September 2024
DEPARTMENT OF INTERNAL MEDICINE, JÓZEF STRUŚ HOSPITAL, POZNAŃ, POLAND.
Cureus
January 2024
Department of Cardiology, Japan Community Healthcare Organization Osaka Hospital, Osaka, JPN.
Pilsicainide is a class Ic antiarrhythmic agent that exhibits fully selective sodium channel blockade. In Japan, it is one of the most prescribed medicines for rhythm control in atrial fibrillation. Pilsicainide is mainly excreted by the kidney.
View Article and Find Full Text PDFCureus
July 2023
Cardiovascular Surgery, Nagoya City University East Medical Center, Nagoya, JPN.
A 79-year-old man presented with impaired consciousness, fever with a body temperature of 41.1°C, and an electrocardiogram showing significant ST segment elevation in leads V1-6, coved-type ST elevation in leads V1-3, and partial right bundle branch block. Echocardiography revealed notable left ventricle dysfunction with apex-based akinesis.
View Article and Find Full Text PDFPol Merkur Lekarski
December 2022
Józef Struś Hospital, Poznań, Poland: Department of Internal Medicine.
Brugada syndrome (BrS) is an inherited channelopathy characterized on ECG by coved (type 1) or saddle-back (type 2) ST-segment elevation (STE) of 2 or more mm in the right precordial leads and is associated with an increased risk of malignant ventricular arrhythmias. The term Brugada phenocopy (BrPh) indicates conditions that may reversibly induce Brugada-like ECG pattern in patients without true BrS; e.g.
View Article and Find Full Text PDFActa Cardiol
June 2019
a Second University Department of Critical Care, Attikon University Hospital, Athens , Greece.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!